LAYERZERO ZRO PRICE PREDICTION 2026
1 extracted signal · 1 resolved · 0 still active
Cilinix CryptoIndependent analyst profile- Source published
- 23 Jan 2026, 15:10 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC
AI-generated source summary
LayerZero (ZROUSDT) has experienced significant bullish momentum, rallying 59% since January 13th, and has now reached a high confluence resistance zone. Key resistance levels include the previous range value area high at $2.33, the previous yearly VWAP at $2.36, and the yearly rolling VWAP at $2.26. Technical indicators show a substantial increase in open interest and positive funding rates, suggesting an overleveraged long market. This accumulation of leverage and the proximity to a major fundamental event (a 'new era' on February 10, 2026), often lead to a 'sell the news' effect. The analysis anticipates a local top with a subsequent pullback towards support levels at $2.10 and $2.00, potentially followed by a bounce and then a deeper correction to $1.85-$1.75, where significant liquidity gaps exist. A bearish divergence upon a retest of resistance would confirm a shorting opportunity.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
Cilinix Crypto
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.